Max Colao
2020
In 2020, Max Colao earned a total compensation of $4.8M as Chief Commercial Officer at Aurinia Pharmaceuticals.
Compensation breakdown
| Bonus | $153,125 |
|---|---|
| Non-Equity Incentive Plan | $212,500 |
| Option Awards | $3,664,488 |
| Salary | $354,167 |
| Stock Awards | $461,040 |
| Total | $4,845,320 |
Colao received $3.7M in option awards, accounting for 76% of the total pay in 2020.
Colao also received $153.1K in bonus, $212.5K in non-equity incentive plan, $354.2K in salary and $461K in stock awards.
Rankings
In 2020, Max Colao's compensation ranked 2,297th out of 13,090 executives tracked by ExecPay. In other words, Colao earned more than 82.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,297 out of 13,090 | 83rd |
Division Manufacturing | 883 out of 5,620 | 84th |
Major group Chemicals And Allied Products | 316 out of 2,253 | 86th |
Industry group Drugs | 268 out of 1,953 | 86th |
Industry Pharmaceutical Preparations | 192 out of 1,458 | 87th |
Source: SEC filing on May 10, 2021.
Colao's colleagues
We found five more compensation records of executives who worked with Max Colao at Aurinia Pharmaceuticals in 2020.
2020
Peter Greenleaf
Aurinia Pharmaceuticals
Chief Executive Officer
2020
Joe Miller
Aurinia Pharmaceuticals
Chief Financial Officer
2020
Stephen Robertson
Aurinia Pharmaceuticals
General Counsel
2020
Max Donley
Aurinia Pharmaceuticals
EVP, Operations and Strategy
2020
Dennis Bourgeault
Aurinia Pharmaceuticals